Acute rejection following orthotopic liver transplantation is a common problem despite current immunosuppressive regimens. Ursodeoxycholic acid (UDCA) has been shown in small, open-labeled studies to prevent rejection episodes, although its effects on complications such as infections, length of hosp
โฆ LIBER โฆ
A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection
โ Scribed by D Barnes; D Talenti; G Cammell; M Goormastic; L Farquhar; M Henderson; D Vogt; J Mayes; MK Westveer; W Carey
- Book ID
- 118686690
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 175 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A randomized clinical trial of ursodeoxy
โ
D Barnes; D Talenti; G Cammell; M Goormastic; L Farquhar; M Henderson; D Vogt; J
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 174 KB
๐ 2 views
A prospective, randomized, double-blind
โ
Fleckenstein, Jaquelyn F. ;Paredes, Melinda ;Thuluvath, Paul J.
๐
Article
๐
1998
๐
Wiley (John Wiley & Sons)
๐
English
โ 68 KB
๐ 1 views
Acute cellular rejection (ACR) after orthotopic liver transplantation occurs in 50% to 80% of patients despite the recent advances in immunosuppressive therapy. Adjuvant use of ursodeoxycholic acid (UDCA) is theoretically attractive, but studies have shown conflicting results. In this randomized, co
Ursodeoxycholic acid (UDCA) reduces hepa
โ
Einspahr, Janine G.; Alberts, David S.; Wameke, James A.; Bozzo, Paul; Basye, Je
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 157 KB
P966 EVALUATION OF THE PREVENTIVE EFFECT
โ
Seidensticker, M.; Seidensticker, R.; Damm, R.; Mohnike, K.; Pech, M.; Sangro, B
๐
Article
๐
2014
๐
Elsevier Science
๐
English
โ 55 KB
Double-blind, randomized, intraindividua
๐
Article
๐
2013
๐
Elsevier Science
๐
English
โ 42 KB